GeoVax Labs (GOVX) EBIT (2016 - 2025)
Historic EBIT for GeoVax Labs (GOVX) over the last 16 years, with Q3 2025 value amounting to -$6.4 million.
- GeoVax Labs' EBIT fell 885.87% to -$6.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$25.5 million, marking a year-over-year decrease of 427.89%. This contributed to the annual value of -$25.1 million for FY2024, which is 597.79% up from last year.
- As of Q3 2025, GeoVax Labs' EBIT stood at -$6.4 million, which was down 885.87% from -$5.4 million recorded in Q2 2025.
- In the past 5 years, GeoVax Labs' EBIT registered a high of -$1.5 million during Q2 2021, and its lowest value of -$13.7 million during Q4 2021.
- Over the past 5 years, GeoVax Labs' median EBIT value was -$5.4 million (recorded in 2025), while the average stood at -$5.4 million.
- As far as peak fluctuations go, GeoVax Labs' EBIT crashed by 92788.53% in 2021, and later surged by 6080.03% in 2022.
- Quarter analysis of 5 years shows GeoVax Labs' EBIT stood at -$13.7 million in 2021, then soared by 60.8% to -$5.4 million in 2022, then crashed by 42.81% to -$7.7 million in 2023, then fell by 8.46% to -$8.3 million in 2024, then rose by 23.62% to -$6.4 million in 2025.
- Its EBIT was -$6.4 million in Q3 2025, compared to -$5.4 million in Q2 2025 and -$5.4 million in Q1 2025.